Analysis of Trial Data for Infliximab and Golimumab: Baseline C-Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis
Analysis of Trial Data for Infliximab and Golimumab: Baseline C-Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now